Skip to main content

International Journal of Clinical Oncology

Ausgabe 11/2021

Inhalt (20 Artikel)

Original Article

Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study

Goshi Nishimura, Daisuke Sano, Yasuhiro Arai, Hideaki Takahashi, Takashi Hatano, Yosuke Kitani, Kentaro Takada, Takashi Wada, Yohei Hiiragi, Nobuhiko Oridate

Open Access Original Article

Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer

Hiroya Taniguchi, Toshiki Masuishi, Akihito Kawazoe, Kei Muro, Shigenori Kadowaki, Hideaki Bando, Shuichi Iino, Rie Kageyama, Takayuki Yoshino

Original Article

Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer

Hiroyuki Okuyama, Yoshinori Kagawa, Toshiki Masuishi, Saori Mishima, Hiromichi Shirasu, Koji Ando, Satoshi Yuki, Kei Muro, Takayuki Yoshino, Kentaro Yamazaki, Eiji Oki, Yoshito Komatsu, Akihito Tsuji

Original Article

Treatment outcome of laparoscopic surgery after self-expandable metallic stent insertion for obstructive colorectal cancer

Yukiharu Hiyoshi, Toshiki Mukai, Toshiya Nagasaki, Tomohiro Yamaguchi, Satoshi Nagayama, Takashi Akiyoshi, Takashi Sasaki, Shoichi Saito, Yosuke Fukunaga

Original Article

Preoperative iron status is a prognosis factor for stage II and III colorectal cancer

Hiroshi Sawayama, Yuji Miyamoto, Kosuke Mima, Rikako Kato, Katsuhiro Ogawa, Yukiharu Hiyoshi, Mototsugu Shimokawa, Takahiko Akiyama, Yuki Kiyozumi, Shiro Iwagami, Masaaki Iwatsuki, Yoshifumi Baba, Naoya Yoshida, Hideo Baba

Original Article

Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer

Mitsuyoshi Tei, Shingo Noura, Masayuki Ohue, Masatoshi Kitakaze, Hidekazu Takahashi, Norikatsu Miyoshi, Mamoru Uemura, Tsunekazu Mizushima, Kohei Murata, Yuichiro Doki, Hidetoshi Eguchi

Open Access Original Article

A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

Mitsuhito Sasaki, Hideki Ueno, Shuichi Mitsunaga, Akihiro Ohba, Hiroko Hosoi, Satoshi Kobayashi, Makoto Ueno, Tetsuji Terazawa, Masahiro Goto, Dai Inoue, Shin Namiki, Yasunari Sakamoto, Shunsuke Kondo, Chigusa Morizane, Masafumi Ikeda, Takuji Okusaka

Open Access Original Article

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

Motohide Uemura, Noboru Nakaigawa, Naoto Sassa, Katsunori Tatsugami, Kenichi Harada, Toshinari Yamasaki, Nobuaki Matsubara, Takuya Yoshimoto, Yuki Nakagawa, Tamaki Fukuyama, Mototsugu Oya, Nobuo Shinohara, Hirotsugu Uemura, Toyonori Tsuzuki

Open Access Correction

Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

Motohide Uemura, Noboru Nakaigawa, Naoto Sassa, Katsunori Tatsugami, Kenichi Harada, Toshinari Yamasaki, Nobuaki Matsubara, Takuya Yoshimoto, Yuki Nakagawa, Tamaki Fukuyama, Mototsugu Oya, Nobuo Shinohara, Hirotsugu Uemura, Toyonori Tsuzuki

Original Article

Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab

Zine‐Eddine Khene, Romain Kokorian, Romain Mathieu, Anis Gasmi, Rioux-Leclercq Nathalie, Kammerer-Jacquet Solène-Florence, Shahrokh Shariat, Renaud de Crevoisier, Brigitte Laguerre, Karim Bensalah

Original Article

Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer

Yuto Baba, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Masashi Matsushima, Yui Nishimoto, Yasuaki Murata, Hirotaka Asakura, Masafumi Oyama, Ryuichi Mizuno, Mototsugu Oya

Original Article

Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy

Kota Iida, Makito Miyake, Kaoru Murakami, Motokiyo Komiyama, Eijiro Okajima, Tomokazu Sazuka, Naotaka Nishiyama, Hiroaki Yasumoto, Takahiro Kimura, Akihiro Ito, Kenichiro Shiga, Atsushi Yamagishi, Hiroshi Kikuchi, Mikio Sugimoto, Rikiya Taoka, Takashi Kobayashi, Takahiro Kojima, Hiroshi Kitamura, Hiroyuki Nishiyama, Kiyohide Fujimoto

Original Article

Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up

Rihito Aizawa, Kiyonao Nakamura, Yoshiki Norihisa, Takashi Ogata, Takahiro Inoue, Toshinari Yamasaki, Takashi Kobayashi, Shusuke Akamatsu, Osamu Ogawa, Takashi Mizowaki

Open Access Original Article

The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer

Masayuki Sekine, Takayuki Enomoto, Yoh Watanabe, Hidetaka Katabuchi, Nobuo Yaegashi, Daisuke Aoki

Open Access Correction

Correction to: The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer

Masayuki Sekine, Takayuki Enomoto, Yoh Watanabe, Hidetaka Katabuchi, Nobuo Yaegashi, Daisuke Aoki

Open Access Original Article

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia

Naoko Hosono, Hisayuki Yokoyama, Nobuyuki Aotsuka, Kiyoshi Ando, Hiroatsu Iida, Takayuki Ishikawa, Kensuke Usuki, Masahiro Onozawa, Masahiro Kizaki, Kohmei Kubo, Junya Kuroda, Yukio Kobayashi, Takayuki Shimizu, Shigeru Chiba, Miho Nara, Tomoko Hata, Michihiro Hidaka, Shin-Ichiro Fujiwara, Yoshinobu Maeda, Yasuyoshi Morita, Mikiko Kusano, Qiaoyang Lu, Shuichi Miyawaki, Erhan Berrak, Nahla Hasabou, Tomoki Naoe

Original Article

Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse

Hiroshi Yasui, Masayuki Kobayashi, Kota Sato, Kanya Kondoh, Tadao Ishida, Yuta Kaito, Hideto Tamura, Hiroshi Handa, Yutaka Tsukune, Makoto Sasaki, Norio Komatsu, Norina Tanaka, Junji Tanaka, Masahiro Kizaki, Toyotaka Kawamata, Junya Makiyama, Kazuaki Yokoyama, Seiya Imoto, Arinobu Tojo, Yoichi Imai

Open Access Original Article

Impact of sarcopenia in advanced and metastatic soft tissue sarcoma

Dennis Strassmann, Bennet Hensen, Viktor Grünwald, Katharina Stange, Hendrik Eggers, Florian Länger, Mohamed Omar, Patrick Zardo, Hans Christiansen, Christoph W. Reuter, Frank K. Wacker, Arnold Ganser, Philipp Ivanyi

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.